What question did this study set out to answer?

This study investigates how age affects warfarin dosage, anticoagulation control, and the risk of major hemorrhage.

February 2, 2018Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyOpen Access

Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage

View Full Paper

Ask AI

Bookmark

Why the study?

Does older age increase the risk of major hemorrhage and affect anticoagulation control in patients receiving warfarin therapy?

Key Points

This study investigates how age affects warfarin dosage, anticoagulation control, and the risk of major hemorrhage.
Analyzed data from 1498 anticoagulated patients categorized by age: young, middle-aged, elderly.
Used regression analysis for warfarin dose and percentage time in target range (PTTR) assessment.
Applied proportional hazards analysis to evaluate risk of major hemorrhage, adjusting for demographic and clinical factors.
Warfarin dose requirements were 10.6% lower for middle-aged and elderly users compared to young users.
Older age groups spent more time in target INR range, despite fewer INR assessments (p<0.0001).
The risk of hemorrhage increased by 31% for each age category compared to young users (p=0.026).

Structured PICO

Does older age increase the risk of major hemorrhage and affect anticoagulation control in patients receiving warfarin therapy?

Population

1,498 anticoagulated patients on warfarin, categorized by age: young (<50 years, 22.8%), middle-aged (50-70 years, 44.1%), and elderly (>70 years, 33.1%).

Intervention

Older age (middle-aged 50-70 years and elderly >70 years) during warfarin therapy

Comparator

Young age (<50 years) during warfarin therapy

Outcome

Warfarin dose (mg/day), percentage time in target range (PTTR), and major hemorrhagesafety

Elderly patients on warfarin require lower doses and achieve better anticoagulation control, yet face a significantly higher risk of major hemorrhage compared to younger patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Older patients need lower warfarin doses with better PTTR yet higher hemorrhage risk; supports cautious dosing but leaves open prospective validation.

Cite This Study

Shendre et al. (2018) studied this question.

synapsesocial.com/papers/6a6f9480a7fbea1e4407c899 https://doi.org/10.1002/phar.2089

Topics

Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Implication

Older patients need lower warfarin doses with better PTTR yet higher hemorrhage risk; supports cautious dosing but leaves open prospective validation.

Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider